Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. (TMO) is a Medical pharmaceuticals company in the Healthcare sector, listed on New York Stock Exchange. This page provides the complete earnings calendar, dividend schedule, and financial data for Thermo Fisher Scientific Inc. in 2026. The next earnings report is expected on October 28, 2026. The upcoming ex-dividend date is September 15, 2026.

Earnings calendar

Next earnings date

28 Oct 2026

In 69 days

EPS estimate

6.37

Revenue estimate

12.0B

Past earnings

23 Jul 2026
EPS actual
6.03 (+5.4%)
estimate 5.72
Revenue actual
12.0B (+2.5%)
estimate 11.7B
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
23 Apr 2026
EPS actual
5.44 (+3.6%)
estimate 5.25
Revenue actual
11.0B (+1.3%)
estimate 10.9B
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
29 Jan 2026
EPS actual
6.57 (+1.9%)
estimate 6.45
Revenue actual
12.2B (+2.2%)
estimate 11.9B
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
22 Oct 2025
EPS actual
5.79 (+5.3%)
estimate 5.50
Revenue actual
11.1B (+1.9%)
estimate 10.9B
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Beat Miss usd

Latest earnings analysis

Thermo Fisher Scientific Inc. beat consensus estimates in its latest earnings report, with EPS of $6.03 coming in 5.4% above expectations and revenue of $11.99 billion exceeding estimates by 2.5%. In the prior quarter both EPS and revenue were also ahead of expectations.

Dividend calendar

Next ex-dividend

15 Sep 2026

In 26 days

Next payment

15 Oct 2026

In 56 days

Dividend amount

0.47

Frequency

Quarterly

Past dividends

Ex-dividend Payment Amount
15 Jun 2026 15 Jul 2026 0.47
13 Mar 2026 15 Apr 2026

EPS (Earnings Per Share)

Revenue

Dividend per share

Company profile

Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.

Sector
Healthcare
Industry
Medical pharmaceuticals
Country
United States
Exchange
New York Stock Exchange
Indices
S&P 500
CEO
Marc N. Casper
Employees
125,000
IPO date
29 Jan 2018
ISIN
US8835561023
Website
thermofisher.com

Frequently asked questions

When does Thermo Fisher Scientific Inc. (TMO) next report earnings?

Thermo Fisher Scientific Inc. (TMO) is scheduled to report earnings on October 28, 2026.

What was Thermo Fisher Scientific Inc.'s most recent earnings date?

Thermo Fisher Scientific Inc. (TMO) last reported earnings on July 23, 2026.

When is the next Thermo Fisher Scientific Inc. ex-dividend date?

The next ex-dividend date for Thermo Fisher Scientific Inc. (TMO) is September 15, 2026, with a payment date of October 15, 2026.

How much is Thermo Fisher Scientific Inc.'s next dividend?

Thermo Fisher Scientific Inc. (TMO) will pay a dividend of 0.47 per share.

How often does Thermo Fisher Scientific Inc. pay dividends?

Based on historical data, Thermo Fisher Scientific Inc. (TMO) pays dividends quarterly.

Where is Thermo Fisher Scientific Inc. stock listed?

Thermo Fisher Scientific Inc. (TMO) is listed on New York Stock Exchange.